We are live on ! Find out more
INBP

INTEGRATED BIOPHARMA INC.
INBP

Delisted

INBP was delisted on the 26th of February, 2009.

Back to rankings

1 hedge funds and large institutions have $7.66K invested in INTEGRATED BIOPHARMA INC. in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $7.04K → $7.66K (+$622)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MSAM
1
Moloney Securities Asset Management
Missouri
$7.66K – – –

INBP Hedge Fund Activity: Q1 2023 in Review

1 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in INTEGRATED BIOPHARMA INC. (INBP) for Q1 2023, worth a combined $7.66K — up 8.8% from $7.04K a quarter earlier.

Fund positioning in INBP was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held INTEGRATED BIOPHARMA INC. (INBP) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $7.66K of INTEGRATED BIOPHARMA INC. stock for Q1 2023, up 8.8% quarter-over-quarter.
  • 0 funds opened new INTEGRATED BIOPHARMA INC. positions in Q1 2023 and 0 closed out.

Based on aggregated 13F filings for Q1 2023.